Co-crystal innovation is an opportunity in drug development for both scientists and industry.
In line with the “green pharmacy” concept for obtaining safer methods and advanced …

Piroxicam (PRM) and meloxicam (MEL) are two nonsteroidal anti-inflammatory drugs,
belonging to the Biopharmaceutics Classification System Class II drugs. In this study, six …

The objective of the existing research was formulation development and preparation of
microemulsion loaded emulgel in augmenting the topical delivery of Lornoxicam. Emulsion …

An increasing proportion of new medicinal substances are poorly soluble in water.
Adsorption on mesoporous silicas increases their bioavailability when administered orally …

Objective The present study was aimed to prepare and characterize new cocrystals of
lornoxicam (LORX), a BCS class II drug employing 1, 3-dimethyl urea (DMU) as a coformer …

The present work is based on the formulation of effervescent granules of lornoxicam unit
dose. Six such formulations were prepared using citric and tartaric acids and sodium …

This study introduces two innovative nanocarrier systems to improve oral drug delivery.
Desosomes and desimicelles combine Deep eutectic solvent (DES) with vesicular or …

Background The research was aimed with an approach to formulate biphasic extended-
release system of trospium chloride resulting in controlled release of drug up to 24 h with …

Accidental Formation of Eutectics during Crystal Engineering of Lamotrigine with Solubility
Advantage and Drug Release Efficienc Page 1 Asian Journal of Pharmaceutics • Jan-Mar …

The chemical synthesis and crystallization steps were integrated successfully for directly
producing a 1: 1 cocrystal of sulfathiazole–theophylline and a 1: 1 cocrystal of sulfathiazole …